[{"Assets_0_Q1_USD":270440000.0,"CommonStockSharesOutstanding_0_Q1_shares":628294702.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-36203000.0,"NetIncomeLoss_1_Q1_USD":-27412000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":627945243.0,"Ticker":"ADAP","CIK":"1621227","name":"ADAPTIMMUNE THERAPEUTICS PLC","OfficialName":"Adaptimmune Therapeutics plc American Depositary Shares","form":"10-Q","period":"20190331","fy":"2019.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"301181409.0","Country":"United Kingdom","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20190506"}]